Dr. Brian Meyer, MD

NPI: 1386697480
Total Payments
$14,821
2023 Payments
$3,486
Companies
1
Transactions
24
Medicare Patients
1,790
Medicare Billing
$214,647

Payment Breakdown by Category

Consulting$11,335 (76.5%)
Other$2,600 (17.5%)
Travel$886.46 (6.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $11,335 18 76.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,650 2 11.1%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $950.00 1 6.4%
Travel and Lodging $886.46 3 6.0%

Top Paying Companies

Company Total Records Latest Year
NOVARTIS PHARMACEUTICALS CORPORATION $14,821 24 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $3,486 6 NOVARTIS PHARMACEUTICALS CORPORATION ($3,486)
2022 $1,787 4 Novartis Pharmaceuticals Corporation ($1,787)
2021 $2,165 4 Novartis Pharmaceuticals Corporation ($2,165)
2018 $6,433 9 Novartis Pharmaceuticals Corporation ($6,433)
2017 $950.00 1 Novartis Pharmaceuticals Corporation ($950.00)

All Payment Transactions

24 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/28/2023 NOVARTIS PHARMACEUTICALS CORPORATION MAYZENT (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $950.00 General
Category: Neurology
11/28/2023 NOVARTIS PHARMACEUTICALS CORPORATION MAYZENT (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $700.00 General
Category: Neurology
11/28/2023 NOVARTIS PHARMACEUTICALS CORPORATION MAYZENT (Drug) Travel and Lodging In-kind items and services $239.08 General
Category: Neurology
06/19/2023 NOVARTIS PHARMACEUTICALS CORPORATION MAYZENT (Drug) Consulting Fee Cash or cash equivalent $950.00 General
Category: Neurology
06/19/2023 NOVARTIS PHARMACEUTICALS CORPORATION MAYZENT (Drug) Travel and Lodging In-kind items and services $500.00 General
Category: Neurology
06/19/2023 NOVARTIS PHARMACEUTICALS CORPORATION MAYZENT (Drug) Travel and Lodging In-kind items and services $147.38 General
Category: Neurology
10/12/2022 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $950.00 General
Category: NEUROSCIENCE
10/12/2022 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $500.00 General
Category: NEUROSCIENCE
10/12/2022 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $219.38 General
Category: NEUROSCIENCE
10/12/2022 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $117.48 General
Category: NEUROSCIENCE
09/14/2021 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $950.00 General
Category: NEUROSCIENCE
09/14/2021 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $350.00 General
Category: NEUROSCIENCE
09/14/2021 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $114.80 General
Category: NEUROSCIENCE
02/05/2021 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
10/08/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $950.00 General
Category: NEUROSCIENCE
09/27/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $150.00 General
Category: NEUROSCIENCE
09/12/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $1,250.00 General
Category: NEUROSCIENCE
09/12/2018 NOVARTIS PHARMACEUTICALS CORPORATION GILENYA (Drug) Consulting Fee Cash or cash equivalent $144.43 General
Category: NEUROSCIENCE
08/24/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $1,250.00 General
Category: NEUROSCIENCE
08/24/2018 NOVARTIS PHARMACEUTICALS CORPORATION GILENYA (Drug) Consulting Fee Cash or cash equivalent $144.43 General
Category: NEUROSCIENCE
08/02/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $1,450.00 General
Category: NEUROSCIENCE
08/02/2018 NOVARTIS PHARMACEUTICALS CORPORATION GILENYA (Drug) Consulting Fee Cash or cash equivalent $144.43 General
Category: NEUROSCIENCE
04/25/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $950.00 General
Category: NEUROSCIENCE
03/03/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program Cash or cash equivalent $950.00 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 380 408 $563,532 $35,451
2022 5 424 452 $581,889 $42,076
2021 5 458 472 $837,965 $62,166
2020 4 528 569 $1.1M $74,954
Total Patients
1,790
Total Services
1,901
Medicare Billing
$214,647
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 144 156 $317,652 $20,216 6.4%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 101 104 $142,793 $8,904 6.2%
99291 Critical care, first 30-74 minutes Facility 2023 32 35 $91,600 $5,662 6.2%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 103 113 $11,487 $668.26 5.8%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 160 169 $339,511 $24,700 7.3%
99284 Emergency department visit for problem of high severity Facility 2022 80 85 $113,345 $7,872 6.9%
99291 Critical care, first 30-74 minutes Facility 2022 33 33 $83,670 $6,215 7.4%
99283 Emergency department visit for problem of moderate severity Facility 2022 46 49 $33,684 $2,578 7.7%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2022 105 116 $11,679 $712.61 6.1%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 236 244 $493,759 $37,936 7.7%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 68 69 $182,605 $14,011 7.7%
99284 Emergency department visit, problem of high severity Facility 2021 94 96 $131,530 $8,198 6.2%
99283 Emergency department visit, moderately severe problem Facility 2021 37 39 $27,823 $1,874 6.7%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2021 23 24 $2,248 $147.43 6.6%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 293 319 $662,803 $44,568 6.7%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 98 105 $282,450 $19,620 6.9%
99284 Emergency department visit, problem of high severity Facility 2020 91 93 $129,055 $8,295 6.4%
99283 Emergency department visit, moderately severe problem Facility 2020 46 52 $38,810 $2,471 6.4%

About Dr. Brian Meyer, MD

Dr. Brian Meyer, MD is a Emergency Medicine healthcare provider based in Jacksonville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386697480.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Meyer, MD has received a total of $14,821 in payments from pharmaceutical and medical device companies, with $3,486 received in 2023. These payments were reported across 24 transactions from 1 company. The most common payment nature is "Consulting Fee" ($11,335).

As a Medicare-enrolled provider, Meyer has provided services to 1,790 Medicare beneficiaries, totaling 1,901 services with total Medicare billing of $214,647. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Location Jacksonville, AR
  • Active Since 05/18/2006
  • Last Updated 08/24/2010
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1386697480

Products in Payments

  • GILENYA (Drug) $11,335
  • MAYZENT (Drug) $3,486

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Jacksonville